heart failure semaglutide may help treat symptoms in type 2 diabetes In patients with cardiometabolic #HFpEF,

Monitor blood sugar more frequently

4.1 Future clinical and research applications 4.1.1 Future research directions While reassuring data are accumulating about the safety profile of GLP-1 receptor agonists (GLP-1 RAs) used for diabetes and obesity management, there are still significant gaps in our understanding that justifies the need for well-designed multidisciplinary translational and clinical studies

Ukhanova M, Wozny JS, Truong CN, Ghosh L, Krause TM

Legumes are low in fat while providing an optimized amount of proteins and vitamins

Conclusion The present study indicated that dietary L-carnitine supplementation could increase the concentrations of carnitine in the liver and muscle, and decrease the lipid content in both tissues, possibly through enhanced mitochondrial -oxidation and reduced adipogenesis

Exenatide was approved by the US FDA in 2005 and by the European Medicines Agency (EMA) in 2006